Mistick Antistaminico (Promethazine Hydrochloride)

Promethazine, the active ingredient in Mistick Antistaminico, is a first‑generation antihistamine presented as a topical formulation for skin application. It is used to relieve itching and inflammation associated with allergic skin reactions and mild dermatitis in patients of all ages.

GNH USA supplies Mistick Antistaminico as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Promethazine acts on histamine‑mediated skin conditions, providing relief from itching and inflammation.

Allergic skin itching (pruritus): reduces the intensity of itching caused by allergic reactions. Mild allergic dermatitis: alleviates redness, swelling, and discomfort in mild eczema or dermatitis. Insect bite irritation: eases localized itching and swelling after insect bites.

Promethazine may cause a range of adverse reactions when applied to the skin.

Common Side Effects: - Local burning or stinging at the application site - Redness or mild erythema - Dryness or peeling of the skin - Pruritus paradoxically worsening - Drowsiness if systemic absorption occurs

Serious or Rare Side Effects: - Severe allergic reaction (angio‑edema, anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Significant sedation or confusion - Cardiac arrhythmias (QT prolongation) - Systemic anticholinergic effects such as urinary retention

Before using Mistick Antistaminico, consider the following safety measures.

Assess patient history: verify no known hypersensitivity to promethazine or other phenothiazines. Avoid broken skin: do not apply on open wounds, abrasions, or inflamed lesions. Limit duration: restrict use to the shortest period necessary to control symptoms. Monitor for sedation: advise patients to avoid operating machinery if drowsiness occurs. Pregnancy and lactation: use only if the prescriber determines benefits outweigh potential risks. Store at ambient temperature: keep in the original container, protect from moisture and light.

Promethazine can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Central nervous system depressants (e.g., alcohol, opioids, benzodiazepines) - Monoamine oxidase inhibitors (MAOIs) within 14 days of use - Other anticholinergic agents that may increase anticholinergic burden - QT‑prolonging medications (e.g., certain antiarrhythmics, macrolide antibiotics)

Moderate Interactions (Monitor Closely): - Other antihistamines, which may enhance sedation - Sedative antihypertensives or muscle relaxants - Drugs metabolized by CYP2D6, as promethazine can inhibit this pathway